This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopv [2024/08/06 15:06] – [The Type III Effector XopV from Xanthomonas] rkoebnik | bacteria:t3e:xopv [2025/02/24 10:17] (current) – jensboch | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== The Type III Effector XopV from // | ====== The Type III Effector XopV from // | ||
- | Author: Coline Sciallano\\ | + | Author: |
Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
Expert reviewer: Seiji Tsuge | Expert reviewer: Seiji Tsuge | ||
Line 19: | Line 19: | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | TT3S-dependent translocation of XopV has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). | + | TT3S-dependent translocation of XopV has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). |
=== Regulation === | === Regulation === | ||
- | //xopV// was shown to contain the PIP-box motif in their promoter region, and the expression was found to be regulated by HrpX using a β -glucuronidase (GUS) reporter assay in // | + | //xopV// was shown to contain the PIP-box motif in their promoter region, and the expression was found to be regulated by HrpX using a beta-glucuronidase (GUS) reporter assay in // |
=== Phenotypes === | === Phenotypes === | ||
- | <font 14px/ | + | Popov //et al.// (2016) reported that // |
- | + | ||
- | <font 14px/ | + | |
- | + | ||
- | <font 14px/ | + | |
=== Localization === | === Localization === | ||
Line 49: | Line 42: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes, examples: | + | Yes (//e.g.//, //X. campestris//, |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
- | Yes, examples: | + | Yes (//e.g.//, // |
===== References ===== | ===== References ===== | ||
Line 65: | Line 58: | ||
Song C, Yang B (2010). Mutagenesis of 18 type III effectors reveals virulence function of XopZ< | Song C, Yang B (2010). Mutagenesis of 18 type III effectors reveals virulence function of XopZ< | ||
- | <font 14px/ | + | Tsuge S, Terashima S, Furutani A, Ochiai H, Oku T, Tsuno K, Kaku H, Kubo Y (2005). Effects on promoter activity of base substitutions in the // |
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||